Sulphonamides: other perfluorooctane sulphonamides

In 2024, sulphonamides: other perfluorooctane sulphonamides trade exhibited slight decline, with global flows reaching $3,273,482 and a three-year compound annual growth rate of -23.0% (five-year: -5.5%). The all-time peak of $18,710,458 was recorded in 2012; the current level is 83% below that high-water mark.

Over the 30-year observation window (1995–2024), 48% of years recorded positive growth, indicating significant cyclicality with frequent contractions. Trend momentum is decelerating (-8.0% acceleration).

The supply side is concentrated (Herfindahl-Hirschman Index 0.431). The three largest exporters — Israel ($6.4M), Barbados ($3.3M), and India ($2.7M) — collectively dominate supply flows. The leading exporter has grown at -97.7% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.125). The three largest import markets are United States ($750.1K), France ($746.5K), and Singapore ($253.6K). The largest importing market sources from 4 different supplying countries.

The dominant trade corridor is Barbados → Japan at $3.2M, representing 99.6% of the importer's total demand.

The volatility score for sulphonamides: other perfluorooctane sulphonamides is 2 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.